Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes

Clinical trial NCT00116831 · COMPLETED

Trial details

NCT number: NCT00116831
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2005-01-01
Primary completion: 2008-08-01
Enrollment: 672

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.